| 1 |
35215555 | Natural Polysaccharide β-Glucan Protects against Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress. | 2022 Feb 21 |
1 |
| 2 |
30275150 | The Endogenous Lusitropic and Chronotropic Agent, B-Type Natriuretic Peptide, Limits Cardiac Troponin Release in Cancer Patients with an Early Impairment of Myocardial Relaxation Induced by Anthracyclines. | 2018 Dec |
1 |
| 3 |
23018571 | Use of cardiac markers for monitoring of doxorubixin-induced cardiotoxicity in children with cancer. | 2012 Nov |
1 |
| 4 |
19938736 | N-terminal pro brain natriuretic peptide and cardiac function in doxorubicin administered pediatric patients. | 2009 Nov |
2 |
| 5 |
17707098 | Combined NT-pro-BNP and CW-Doppler ultrasound cardiac output monitoring (USCOM) in epirubicin and liposomal doxorubicin therapy. | 2008 Aug 29 |
2 |
| 6 |
16127512 | Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy. | 2005 Aug |
2 |
| 7 |
11886482 | Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction. | 2002 Mar |
2 |
| 8 |
11466716 | Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer. | 2001 Jul |
1 |